Devices descending from K122547
5 later devices reach Gram Postitve Clindamycin through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +1 | K141149 | Vitek 2 Ast GP Ceftaroline | bioMerieux, Inc. | 2014 | 4 | — |
| +2 | K190616 | VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL) | bioMerieux, Inc. | 2019 | 3 | — |
| +3 | K212243 | VITEK 2 AST- Gram Positive Telavancin (<=0.015 - >=1 µg/mL) | bioMerieux, Inc. | 2022 | 0 | — |
| +3 | K202396 | VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL) | bioMerieux, Inc. | 2021 | 0 | — |
| +3 | K200590 | VITEK 2 AST-Gram Positive Delafloxacin (<=0.015 - >=1 µg/mL) | bioMerieux, Inc. | 2020 | 0 | — |